Matsuo N - Search Results

1

Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer.

Ibusuki R, Yoneshima Y, Hashisako M, Matsuo N, Harada T, Tsuchiya-Kawano Y, Kishimoto J, Ota K, Shiraishi Y, Iwama E, Tanaka K, Oda Y, Okamoto I. Ibusuki R, et al. Among authors: matsuo n. Transl Lung Cancer Res. 2022 Nov;11(11):2208-2215. doi: 10.21037/tlcr-22-393. Transl Lung Cancer Res. 2022. PMID: 36519019 Free PMC article.

2

Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.

Tokito T, Azuma K, Kawahara A, Ishii H, Yamada K, Matsuo N, Kinoshita T, Mizukami N, Ono H, Kage M, Hoshino T. Tokito T, et al. Among authors: matsuo n. Eur J Cancer. 2016 Mar;55:7-14. doi: 10.1016/j.ejca.2015.11.020. Epub 2016 Jan 6. Eur J Cancer. 2016. PMID: 26771872

3

Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy.

Ishii H, Azuma K, Yamada K, Matsuo N, Nakamura M, Tokito T, Kinoshita T, Hoshino T. Ishii H, et al. Among authors: matsuo n. BMJ Open Respir Res. 2017 Jan 10;4(1):e000163. doi: 10.1136/bmjresp-2016-000163. eCollection 2017. BMJ Open Respir Res. 2017. PMID: 28123750 Free PMC article.

4

Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients.

Takeoka H, Yamada K, Naito Y, Matsuo N, Ishii H, Tokito T, Azuma K, Ichiki M, Hoshino T. Takeoka H, et al. Among authors: matsuo n. Anticancer Res. 2018 Jun;38(6):3779-3784. doi: 10.21873/anticanres.12661. Anticancer Res. 2018. PMID: 29848743 Clinical Trial.

5

Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitor.

Matsuo N, Azuma K, Hattori S, Ohtake J, Kawahara A, Ishii H, Tokito T, Yamada K, Shibata Y, Shimokawaji T, Kondo T, Kato T, Saito H, Yamada K, Sasada T, Hoshino T. Matsuo N, et al. Int J Cancer. 2019 Mar 1;144(5):1170-1179. doi: 10.1002/ijc.31923. Epub 2018 Nov 12. Int J Cancer. 2019. PMID: 30307035 Free article.

6

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC.

Ishii H, Azuma K, Kawahara A, Kinoshita T, Matsuo N, Naito Y, Tokito T, Yamada K, Akiba J, Hoshino T. Ishii H, et al. Among authors: matsuo n. Thorac Cancer. 2020 Apr;11(4):950-955. doi: 10.1111/1759-7714.13346. Epub 2020 Feb 15. Thorac Cancer. 2020. PMID: 32061060 Free PMC article.

7

Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy.

Ishii H, Azuma K, Kawahara A, Matsuo N, Tokito T, Hoshino T. Ishii H, et al. Among authors: matsuo n. Invest New Drugs. 2021 Feb;39(1):269-271. doi: 10.1007/s10637-020-00983-6. Epub 2020 Aug 11. Invest New Drugs. 2021. PMID: 32783090

8

Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy.

Matsuo N, Azuma K, Kojima T, Ishii H, Tokito T, Yamada K, Hoshino T. Matsuo N, et al. Invest New Drugs. 2021 Aug;39(4):1150-1158. doi: 10.1007/s10637-021-01069-7. Epub 2021 Jan 22. Invest New Drugs. 2021. PMID: 33483882

9

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.

Murata D, Azuma K, Matama G, Zaizen Y, Matsuo N, Murotani K, Tokito T, Hoshino T. Murata D, et al. Among authors: matsuo n. Thorac Cancer. 2023 Jan;14(1):73-80. doi: 10.1111/1759-7714.14718. Epub 2022 Nov 14. Thorac Cancer. 2023. PMID: 36377039 Free PMC article.

10

Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.

Matsuo N, Azuma K, Murotani K, Murata D, Matama G, Kawahara A, Kojima T, Tokito T, Hoshino T. Matsuo N, et al. Thorac Cancer. 2023 May;14(15):1362-1367. doi: 10.1111/1759-7714.14881. Epub 2023 Apr 10. Thorac Cancer. 2023. PMID: 37037511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

900 results

Search Page